Abbott Laboratories (ABT.SW)

CHF 93.5

(0.0%)

Revenue Summary of Abbott Laboratories

  • Abbott Laboratories's latest annual revenue in 2023 was 40.1 Billion USD , down -8.12% from previous year.
  • Abbott Laboratories's latest quarterly revenue in 2024 Q2 was 10.37 Billion USD , up 4.14% from previous quarter.
  • Abbott Laboratories reported a annual revenue of 43.65 Billion USD in annual revenue 2022, up 1.34% from previous year.
  • Abbott Laboratories reported a annual revenue of 43.07 Billion USD in annual revenue 2021, up 24.47% from previous year.
  • Abbott Laboratories reported a quarterly revenue of 10.37 Billion USD for 2024 Q2, up 4.14% from previous quarter.
  • Abbott Laboratories reported a quarterly revenue of 40.1 Billion USD for 2023 FY, down -8.12% from previous quarter.

Annual Revenue Chart of Abbott Laboratories (2023 - 1989)

Historical Annual Revenue of Abbott Laboratories (2023 - 1989)

Year Revenue Revenue Growth
2023 40.1 Billion USD -8.12%
2022 43.65 Billion USD 1.34%
2021 43.07 Billion USD 24.47%
2020 34.6 Billion USD 8.48%
2019 31.9 Billion USD 4.34%
2018 30.57 Billion USD 11.64%
2017 27.39 Billion USD 31.35%
2016 20.85 Billion USD 2.2%
2015 20.4 Billion USD 0.78%
2014 20.24 Billion USD -7.33%
2013 21.84 Billion USD -45.21%
2012 39.87 Billion USD 2.63%
2011 38.85 Billion USD 10.48%
2010 35.16 Billion USD 14.31%
2009 30.76 Billion USD 4.19%
2008 29.52 Billion USD 13.94%
2007 25.91 Billion USD 15.3%
2006 22.47 Billion USD 0.62%
2005 22.33 Billion USD 13.51%
2004 19.68 Billion USD -0.0%
2003 19.68 Billion USD 11.29%
2002 17.68 Billion USD 8.59%
2001 16.28 Billion USD 18.47%
2000 13.74 Billion USD 4.31%
1999 13.17 Billion USD 5.61%
1998 12.47 Billion USD 5.0%
1997 11.88 Billion USD 7.9%
1996 11.01 Billion USD 10.0%
1995 10.01 Billion USD 9.35%
1994 9.15 Billion USD 8.9%
1993 8.4 Billion USD 7.08%
1992 7.85 Billion USD 14.18%
1991 6.87 Billion USD 11.66%
1990 6.15 Billion USD 14.48%
1989 5.37 Billion USD 8.97%

Peer Revenue Comparison of Abbott Laboratories

Name Revenue Revenue Difference
Medartis Holding AG 212 Million CHF -18818.804%
Sonova Holding AG 3.62 Billion CHF -1005.876%